___

1. Dubchak N, Falasca GF. New and improved strategies for the treatment of gout. Int J Nephrol Dis 2010; 3:145-66.

2. Lee KA, Yoo WH. Immobilization hypercalcemia-associated acute renal failure in a patient with chronic tophaceous gout. Ren Fail 2009; 31:855-7. doi:10.3109/08860220903151393

3. Moon KW, Kim JH, Song R, Lee EY, Song YW, Lee EB. Risk factors for acute kidney injury by non-steroidal anti-inflammatory drugs in patients with hyperuricemia. Rheumatology (Oxford). 2011;50:2278-82. doi:10.1093/rheumatology/ker286

4. Stamp LK, Jordan S. The challenges of gout management in the elderly. Drugs Aging 2011;28:591-603. doi:10.2165/11592750-000000000-00000

5. Park SH, Shin WY, Lee EY, et al. The impact of hyperuricemia on in- Hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention. Circulation J 2011;75:692-7. doi:10.1253/circj.CJ-10-0631

6. Zychowicz ME, Pope RS, Graser E. The current state of care in gout: addressing the need for better understanding of an ancient disease. J Am Acad Nurse Pract 2010;22(Suppl 1):623-36. doi:10.1111/j.1745-7599.2010.00556.x

7. Goldenstein-Schainberg C, Favarato MHS, Ranza R. Current and relevant concepts in psoriatic arthritis. Rev Bras Reumatol 2012;52:92-106.

8. Fischman D, Valluri A, Gorrepati VS, Murphy ME, Peters I, Cheriyath P. Bilirubin as a protective factor for rheumatoid arthritis: an NHANES study of 2003-2006 data. J Clin Med Res 2010;2:256-60. doi:10.4021/jocmr444w